BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1417804)

  • 21. Role of the pseudosubstrate sequence in smooth muscle myosin light chain kinase thermal stability.
    Faux MC; Pearson RB; Mitchelhill KI; Kemp BE
    J Biol Chem; 1993 Jun; 268(17):12484-91. PubMed ID: 8509388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary structure required for the inhibition of smooth muscle myosin light chain kinase.
    Ikebe M; Reardon S; Fay FS
    FEBS Lett; 1992 Nov; 312(2-3):245-8. PubMed ID: 1426258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Location of the inhibitory region of smooth muscle myosin light chain kinase.
    Ikebe M; Maruta S; Reardon S
    J Biol Chem; 1989 Apr; 264(12):6967-71. PubMed ID: 2708351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-correlation of phosphorylation of the P-light chain and the actin activation of the ATPase of chicken gizzard myosin.
    Cole HA; Grand RJ; Perry SV
    Biochem J; 1982 Aug; 206(2):319-28. PubMed ID: 6128971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
    Nakajima T; Katoh A
    Mol Pharmacol; 1987 Jul; 32(1):140-6. PubMed ID: 3037298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of felodipine, nitrendipine and W-7 on arterial myosin phosphorylation, actin-myosin interactions and contraction.
    Silver PJ; Ambrose JM; Michalak RJ; Dachiw J
    Eur J Pharmacol; 1984 Jul; 102(3-4):417-24. PubMed ID: 6489434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of smooth muscle myosin light chain kinase activity by a monoclonal antibody which recognizes the calmodulin-binding region.
    Araki Y; Ikebe M
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):679-84. PubMed ID: 1710106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superprecipitation of gizzard actomyosin, and tension in gizzard muscle skinned fibers in the presence of nucleotides other than ATP.
    Cassidy P; Kerrick WG
    Biochim Biophys Acta; 1982 Jul; 705(1):63-9. PubMed ID: 7115732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mode of inhibition of smooth muscle myosin light chain kinase by synthetic peptide analogs of the regulatory site.
    Ikebe M
    Biochem Biophys Res Commun; 1990 Apr; 168(2):714-20. PubMed ID: 2334433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of NA0344, a new smooth muscle relaxant, on the actin-myosin-ATP interaction and myosin light chain phosphorylation in vitro.
    Kohama K; Hiramura T; Takano-Ohmuro H; Ozaki H; Karaki H; Hachisu M
    Gen Pharmacol; 1991; 22(3):465-74. PubMed ID: 1869018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphosphorylation of platelet myosin by myosin light chain kinase.
    Itoh K; Hara T; Shibata N
    Biochim Biophys Acta; 1992 Feb; 1133(3):286-92. PubMed ID: 1531301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid hormones directly interact with vascular smooth muscle strips.
    Ishikawa T; Chijiwa T; Hagiwara M; Mamiya S; Hidaka H
    Mol Pharmacol; 1989 Jun; 35(6):760-5. PubMed ID: 2733694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of cDNA for bovine stomach 155 kDa protein exhibiting myosin light chain kinase activity.
    Kobayashi H; Inoue A; Mikawa T; Kuwayama H; Hotta Y; Masaki T; Ebashi S
    J Biochem; 1992 Dec; 112(6):786-91. PubMed ID: 1284247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of calcium antagonists and vasodilators on arterial myosin phosphorylation and actin-myosin interactions.
    Silver PJ; Dachiw J; Ambrose JM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):141-8. PubMed ID: 6747823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping myosin-binding sites on actin probed by peptides that inhibit actomyosin interaction.
    Katoh T; Morita F
    J Biochem; 1996 Sep; 120(3):580-6. PubMed ID: 8902624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide modulators of myosin light chain kinase affect smooth muscle cell contraction.
    Kargacin GJ; Ikebe M; Fay FS
    Am J Physiol; 1990 Aug; 259(2 Pt 1):C315-24. PubMed ID: 2116724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of phosphorylation of smooth-muscle caldesmon.
    Ngai PK; Walsh MP
    Biochem J; 1987 Jun; 244(2):417-25. PubMed ID: 2822003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of skeletal muscle myosin light chain phosphorylation on synthetic actomyosin ATPase activity and superprecipitation.
    Kalapos I; Stepkowski D; Csabina S; Szöór A
    Acta Biochim Biophys Hung; 1989; 24(3):231-43. PubMed ID: 2535028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.